Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Jacqueline V. Aredo; Isa Mambetsariev; Jessica A. Hellyer; Arya Amini; Joel W. Neal

doi:10.1016/j.jtho.2021.01.1628

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Jacqueline V. Aredo, Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda, Caroline E. McCoach, Jonathan W. Riess, Elwyn C. Cabebe, Jarushka Naidoo, Tariq Abuali, Ravi Salgia, Billy W. Loo, Maximilian Diehn, Summer S. Han...

Elsevier BV (2021) • Volume 16, Issue 6, Pages 1030-1041

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1016/j.jtho.2021.01.1628

Language

English

Topic

Cancer Immunotherapy and Biomarkers

Keywords

Durvalumab, Medicine, Pneumonitis, Osimertinib, Chemoradiotherapy, Internal medicine, Adverse effect, Oncology, Cancer, Nivolumab, Immunotherapy, Epidermal growth factor receptor, Lung, Erlotinib

Published

February 15, 2021

Citations

125 citations

FWCI

11.22

External Resources

DOI Link OpenAlex

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Quick Actions

Publication Info

External Resources

Suggested Papers

European guideline for the diagnosis and treatment of insomnia

Long COVID and the Increased Risk of Food Insecurity Among Participants in Arizona CoVHORT: A matched cohort study

Long-Term Dietary Strawberry, Spinach, or Vitamin E Supplementation Retards the Onset of Age-Related Neuronal Signal-Transduction and Cognitive Behavioral Deficits

Suggested Papers

Suggested Papers

European guideline for the diagnosis and treatment of insomnia

Long COVID and the Increased Risk of Food Insecurity Among Participants in Arizona CoVHORT: A matched cohort study

Long-Term Dietary Strawberry, Spinach, or Vitamin E Supplementation Retards the Onset of Age-Related Neuronal Signal-Transduction and Cognitive Behavioral Deficits